George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM & Proposed Changes to Option Scheme

3 Apr 2023 07:00

RNS Number : 0423V
Osirium Technologies PLC
03 April 2023
 

03 April 2023

 

Osirium Technologies plc

("Osirium", the "Group" or the "Company")

 

Posting of annual report and accounts, notice of AGM,

proposed amendments to share option plan and proposed grant of options

 

Posting of accounts and notice of AGM

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces that the Company's annual report and accounts for the year ended 31 December 2022, which incorporates notice of the Company's 2023 Annual General Meeting ("AGM") will shortly be posted to shareholders who have elected to receive a hard copy of them and will be available to download from the Company's website at www.osirium.com.

 

The AGM will be held at the Company's offices at Theale Court, 11-13 High Street, Theale, RG7 5AH at 11:00 a.m. on Tuesday, 9 May 2023.

 

Proposed amendments to share option scheme and grant of options

 

The AGM notice contains a resolution (the "Plan Resolution") to permit the Directors to make certain amendments to the Company's Enterprise Management Incentive (EMI) Share Option Plan 2020-2025 (the "Plan"), including, inter alia, the ability to set the exercise price of new options granted pursuant to the Plan equal to the market price of an ordinary share in the Company ("Ordinary Share") at the date of grant.

 

The Plan was put in place in 2020 with a primary goal of incentivising and retaining Directors and key employees of the Company to drive the Company's future growth and share value. The current Plan rules do not permit the grant of options with an exercise price of less than 35p per option, being a premium of over 2000% to the current mid-market price of an Ordinary Share. Accordingly, Osirium's remuneration committee has proposed amendments to the scheme to confer wider discretion on the Board to grant options over Ordinary Shares at no lesser amount than the market value of the Company's shares at the date of grant, and exercisable on conditions and at vesting periods which they regard as more aligned with the interests of the Company to provide meaningful and achievable incentives to the Company's directors and staff.

 

Furthermore, the existing options granted pursuant to the Plan have an exercise price of 35p and the Company has historic options outstanding granted pursuant to the Osirium Technologies plc Enterprise Management Incentive (EMI) Share Option Plan 2016, adopted at the time of the Company's IPO, which have exercise prices of between 41.67p and 187.2p per Ordinary Share. The Board does not consider that any of these options provide a meaningful incentive to option holders.

 

Subject to the passing of the Plan Resolution at the AGM and shortly following the conclusion of the AGM, it is anticipated that all existing holders of outstanding options over Ordinary Shares will be invited to surrender their current options and would be granted new options (the "New Options"), exercisable at the market price of an Ordinary Share at the time of grant, such number of options to be determined by Osirium's Remuneration Committee. It is anticipated that the New Options would be subject to a three-year vesting period, with the options vesting as to: one third on the first anniversary of grant; one third on the second anniversary of grant; and one third on the third anniversary of grant.

 

It is anticipated that the following number of options would be granted to Directors and PDMRs of the Company:

 

Director

No. of existing options currently held and to be surrendered

No. of New Options to be granted

Percentage of existing issued share capital of the Company represented by the New Options

David Guyatt (Chairman)

1,061,416

1,225,487

1.00%

Stuart McGregor (CEO)

218,500

2,450,974

2.00%

Rupert Hutton (CFO)

147,250

1,225,487

1.00%

Simon Lee (NED)

147,250

183,823

0.15%

Simon Hember (NED)

26,125

183,823

0.15%

Catherine Jamieson

(wife of David Guyatt)

180,000

612,743

0.50%

 

Full details of the proposed amendments to the Plan are set out in the explanatory notes to the notice of AGM. Should the Plan Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Plan or grant the New Options. A further announcement will be made on conclusion of the AGM.

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAEALLAEDKDEFA
Date   Source Headline
31st Oct 20237:00 amRNSCancellation - Osirium Technologies plc
30th Oct 202310:39 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
30th Oct 20237:30 amRNSSuspension - Osirium Technologies plc
26th Oct 202311:22 amRNSCourt Sanction of Scheme of Arrangement
12th Oct 20233:09 pmRNSResults of Court Meeting and General Meeting
28th Sep 20234:33 pmRNSForm 8.3 - Osirium Technologies plc
27th Sep 20231:36 pmRNSForm 8.3 - Osirium Technologies plc
18th Sep 20237:00 amRNSPublication and Posting of Scheme Document
14th Sep 20231:34 pmRNSForm 8.3 - Osirium Technologies PLC
8th Sep 20232:08 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20234:09 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20237:00 amRNSInterim Results
5th Sep 20233:14 pmGNWCorrection: Form 8.3 - Octopus Investments - Osirium Technologies plc
5th Sep 20237:00 amRNSForm 8 (OPD) Osirium Technologies plc
1st Sep 20234:58 pmRNSForm 8.3 - Osirium Technologies plc
1st Sep 202311:10 amRNSForm 8.3 - Osirium Technologies plc- Amendment
31st Aug 20234:24 pmRNSForm 8.3 - Osirium Technologies PLC
31st Aug 20232:02 pmGNWForm 8.3 - Osirium Technologies plc
31st Aug 202311:28 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 202310:51 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 20239:50 amRNSForm 8 (DD) - Osirium Technologies plc
30th Aug 202312:00 pmRNSRecommended Acquisition of Osirium Technologies
18th Jul 20237:00 amRNSHalf Year Trading Update
13th Jun 20237:00 amRNSAttendance at InfoSec Europe 2023
22nd May 20237:00 amRNSGrant of Options and PDMR Dealings
9th May 202312:40 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Statement and Q1 trading update
18th Apr 20237:00 amRNSUpdate re proposed grant of options
3rd Apr 20237:00 amRNSNotice of AGM & Proposed Changes to Option Scheme
24th Mar 20234:40 pmRNSSecond Price Monitoring Extn
24th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20237:00 amRNSFinal Results
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20239:00 amRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSFull Year Trading Update
4th Jan 202311:59 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSConfirmation of Board Changes
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 202210:30 amRNSHoldings in Company
15th Dec 202211:51 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20222:25 pmRNSHolding(s) in Company
12th Dec 202210:19 amRNSResult of General Meeting
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:12 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:11 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:10 pmRNSTR-1: Notification of Major Holdings
22nd Nov 20227:00 amRNSProposed Placing, Subscription, Board Changes & GM
1st Nov 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.